Zentalis Pharmaceuticals News

Zentalis Pharmaceuticals | DEFA14A: Others

Apr 29 16:44 ET

Zentalis Pharmaceuticals | DEF 14A: Definitive information statements

Apr 29 16:42 ET

Zentalis Pharmaceuticals | ARS: Annual Report to Security Holders

Apr 29 16:39 ET

Zentalis Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Vultaggio Vincent

Apr 11 07:04 ET

Zentalis Pharmaceuticals | 8-K: Current report

Apr 11 07:04 ET

Zentalis Pharmaceuticals | 8-K: Current report

Apr 9 16:36 ET

Zentalis Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 29 17:25 ET

Zentalis Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 29 17:20 ET

Zentalis Pharmaceuticals | 10-K: Annual report

Feb 27 07:15 ET

Zentalis Pharmaceuticals | 8-K: Current report

Feb 27 07:05 ET

Zentalis Pharmaceuticals | 8-K: Current report

Feb 15 16:20 ET

Zentalis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(5.3%),Citadel Advisors LLC(5.1%), etc.

Feb 14 17:04 ET

Zentalis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.56%)

Feb 13 22:18 ET

Zentalis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(0%),Avidity Partners Management (GP) LLC(0%), etc.

Feb 13 19:46 ET

Zentalis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 12 20:31 ET

Zentalis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 12 20:31 ET

Zentalis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 12 20:25 ET

Zentalis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Epperly Melissa B,

Feb 12 20:25 ET

Zentalis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gallagher Cam

Feb 12 20:25 ET

Zentalis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital International Investors(4.0%)

Feb 9 18:10 ET